Wenjie Deng

The zinc-finger protein CNBP is required for forebrain formation in the mouse.

Coping with viral diversity in HIV vaccine design.

ViroBLAST: a stand-alone BLAST web server for flexible queries of multiple databases and user's datasets.

Recognition of HIV-1 peptides by host CTL is related to HIV-1 similarity to human proteins.

Broad and Gag-biased HIV-1 epitope repertoires are associated with lower viral loads.

Env length and N-linked glycosylation following transmission of human immunodeficiency virus Type 1 subtype B viruses.

Rare HLA drive additional HIV evolution compared to more frequent alleles.

HIV-1 superinfection in the antiretroviral therapy era: are seroconcordant sexual partners at risk?

Conserved HIV-1 epitopes continuously elicit subdominant cytotoxic T-lymphocyte responses.

Phylogenetic analysis of population-based and deep sequencing data to identify coevolving sites in the nef gene of HIV-1.

DIVEIN: a web server to analyze phylogenies, sequence divergence, diversity, and informative sites.

Amino-acid co-variation in HIV-1 Gag subtype C: HLA-mediated selection pressure and compensatory dynamics.

HIV-1 envelope subregion length variation during disease progression.

Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial.

Viral linkage in HIV-1 seroconverters and their partners in an HIV-1 prevention clinical trial.

Increased breadth and depth of cytotoxic T lymphocytes responses against HIV-1-B Nef by inclusion of epitope variant sequences.

Demographic processes affect HIV-1 evolution in primary infection before the onset of selective processes.

Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2.

Indel and Carryforward Correction (ICC): a new analysis approach for processing 454 pyrosequencing data.

Quality score based identification and correction of pyrosequencing errors.

Improved detection of rare HIV-1 variants using 454 pyrosequencing.

Validation of an oligonucleotide ligation assay for quantification of human immunodeficiency virus type 1 drug-resistant mutants by use of massively parallel sequencing.

Analysis of HLA A*02 association with vaccine efficacy in the RV144 HIV-1 vaccine trial.

CD8 and CD4 epitope predictions in RV144: no strong evidence of a T-cell driven sieve effect in HIV-1 breakthrough sequences from trial participants.

Performance of commonly used genotypic assays and comparison with phenotypic assays of HIV-1 coreceptor tropism in acutely HIV-1-infected patients.